Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD)

NCT01971970 · clinicaltrials.gov ↗

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

BIOLOGICAL: Infliximab
BIOLOGICAL: Adalimumab

Sponsor

Erasmus Medical Center

Collaborators

[object Object]